Osaic Holdings’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-576
Closed -$627 7457
2024
Q4
$627 Hold
576
﹤0.01% 6962
2024
Q3
$765 Hold
576
﹤0.01% 6916
2024
Q2
$518 Hold
576
﹤0.01% 6974
2024
Q1
$886 Sell
576
-33
-5% -$46 ﹤0.01% 6709
2023
Q4
$1.69K Hold
609
﹤0.01% 6589
2023
Q3
$5.34K Sell
609
-104
-15% -$1.01K ﹤0.01% 6246
2023
Q2
$7.41K Hold
713
﹤0.01% 6123
2023
Q1
$8.69K Buy
713
+575
+417% +$8.97K ﹤0.01% 6053
2022
Q4
$3K Hold
138
﹤0.01% 6477
2022
Q3
$3K Buy
138
+19
+16% +$519 ﹤0.01% 6582
2022
Q2
$4K Buy
+119
New +$7.22K ﹤0.01% 6561
2022
Q1
Sell
-20
Closed -$3K 7238
2021
Q4
$3K Buy
+20
New +$2.19K ﹤0.01% 6850

Other funds holding BFRI

Osaic Holdings's BFRI Position: Q1 2025 in Review

Osaic Holdings sold out of Biofrontera (BFRI) in Q1 2025, closing a stake of 576 shares — an estimated $627 sold.

Osaic Holdings first reported a position in BFRI in Q4 2021 and held it in 12 quarters. The position peaked at $8.69K in Q1 2023. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2025.

  • Osaic Holdings reported no remaining Biofrontera position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 576 Biofrontera shares in Q1 2025, an estimated $627.
  • Osaic Holdings first reported a position in Biofrontera in Q4 2021 and held it in 12 quarters.
  • Osaic Holdings's Biofrontera position peaked at $8.69K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.